Bridging Science and Strategy: Medical Affairs at the Heart of Omnichannel Engagement

In this video podcast hosted by Pharmaphorum, Editor in Chief Jonah Comstock speaks with Cheryl Lubbert, co-founder and CEO of Reverba Global, and Carolyn Whiting, SVP of Clinical and Medical Client Services. They discuss Reverba Global’s approach to true omnichannel patient and physician engagement, giving examples and insights on how they are overcoming the challenges…

|

In this video podcast hosted by Pharmaphorum, Editor in Chief Jonah Comstock speaks with Cheryl Lubbert, co-founder and CEO of Reverba Global, and Carolyn Whiting, SVP of Clinical and Medical Client Services.

They discuss Reverba Global’s approach to true omnichannel patient and physician engagement, giving examples and insights on how they are overcoming the challenges and building this new paradigm. Tune in to find out how this approach can help your organisation build better connections with patients and HCPs.

Watch here:Bridging Science and Strategy

The Latest

  • From HBA GALE 2026: Why the Future of Healthcare Still Depends on Something Very Human
    From HBA GALE 2026: Why the Future of Healthcare Still Depends on Something Very Human

    Mentorship, community, and human-centered connection play a central role in shaping healthcare. While technology accelerates innovation, trust, collaboration, and human insight remain essential to advancing leadership, patient care, and organizational…

  • The Missing Moment: When Patient Voice Enters Strategy Too Late
    The Missing Moment: When Patient Voice Enters Strategy Too Late

    Patient insight often enters strategy after key decisions are already set, limiting its ability to shape evidence, positioning, and adoption. Introduced earlier, it informs the choices that drive differentiation, value…

  • How FDA Scrutiny and Patient Behavior Are Reshaping DTC’s Role in the US
    How FDA Scrutiny and Patient Behavior Are Reshaping DTC’s Role in the US

    DTC still drives awareness in the US, but it does not consistently support patient action on its own. FDA scrutiny and more complex patient journeys are shifting its role within…

See More Insights